Bibliography
- FOLKMAN J: Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. (2002) 29(6 Supp1.16):15–18.
- •A good overview.
- WALSH DA: Angiogenesis and arthritis. Rheumatology (1999) 38:103–112.
- FERRARA N, ALITALO K: Clinical application of angiogenic growth factors and their inhibitors. Nat. Med. (1999) 5(12):1359–1364.
- FERRARA N: Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin. Oncol (2002) 29(6 Supp1.16):10–14.
- FERRARA N: Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. (1999) 56:794–814.
- CARMELIET P: Angiogenesis in health and disease. Nat. Med. (2003) 9(6):653–660.
- •A recent review on angiogenesis.
- BOYER SJ: Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationships. Corr. Top. Med. Chem. (2002)2:973–1000.
- ••An extremely well documented medicinalchemistry review.
- CONNELL RD: Patent focus on cancer chemotherapeutics V. Angiogenesis agents: September 2001 - August 2003. Expert Opin. Ther. Patents (2002) 12:1763–1782.
- •A recently updated medicinal chemistry review.
- TUCKER TJ, CIECKO PA, COLL KE et al.: Synthesis and biological evaluation of a series of novel and potent inhibitors of KDR kinase. 224th ACS National Meeting, Boston, USA (2002) MEDI220.
- FRALEY ME, ANTANAVAGE J, ARRINGTON KL et al: Discovery, synthesis, SAR, and in vitrol in vivo characterization of a novel quinolinone class of VEGFR-2 kinase inhibitors. 224th ACS National Meeting, Boston, USA (2002) MEDI221.
- MISRA R, XIAO H Y, KIM K et al: Discovery and development of acy1-2-aminothiazole cyclin-dependent kinase inhibitors with potent in vivo anti-tumor activity. 223th ACS National Meeting, Orlando, USA (2002) MEDI251.